SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Robert K. who wrote (8839)2/24/1999 10:19:00 AM
From: aknahow  Read Replies (2) | Respond to of 17367
 
What's wrong with this picture? Fool me once...
Liar, liar.

NEW TEST TO PREVENT MENINGITIS OUTBREAKS

A new test to identify the different strains of meningitis could help to prevent further outbreaks
of the killer disease which claims the lives of scores of British children each year.

Developed by a research team at the University of Surrey and the Gloucester Public Health
Laboratory, the new test means that scientists will be able to identify meningitis bugs inside a
patient's blood cells by literally fishing a very small piece of meningitis DNA out of the sea of
human DNA present in a blood sample.

"There are around one hundred different strains of the meningitis bacteria," said Dr Johnjoe
McFadden leader of the Surrey research team. "In incidents of meningitis, doctors urgently
need to know the strain of bacteria involved, both to search for the source of disease and to
decide whether to vaccinate children at risk," he added.

Traditional typing (distinguishing between strains) often fails due to antibiotics that leave the
bacteria unable to grow in the laboratory. Using the test to isolate a small piece of meningitis
DNA from a blood sample, this DNA is then allowed to fold into a characteristic shape that can
be easily identified - each strain adopts a different shape.

"We hope that this technique will help to prevent further outbreaks of this devastating disease
that kills scores of British children each year and results in thousands of deaths worldwide,"
said Dr McFadden.

The work of Dr McFadden's team was funded by the National Meningitis Trust.

Further information is available from Dr Johnjoe McFadden on 01483 300800 ext 2671 or
Colin McCallum, University of Surrey Press Office on 01483 259236.

Note to Editors

Dr McFadden's team last year developed a rapid blood test to diagnose meningitis without the
need for a painful lumbar puncture. This test is now widely used by laboratories throughout
the UK.

27 June 1997




To: Robert K. who wrote (8839)2/24/1999 11:00:00 AM
From: Cacaito  Read Replies (2) | Respond to of 17367
 
RobertK, the Anca resistant characteristic of rBPI21 and other variants are very important, this made the product more valuable.